Table 1.
The expression profile of FXYD6 in human tissues
| Type of tissues | Positive/Total | Positive (%) | P-value | |
|---|---|---|---|---|
| Liver | Hepatocellular carcinoma | 54/56 | 96 | P < 0.01 |
| Normal tissue | 11/35 | 31 | ||
| Thyroid | Carcinoma | 17/17 | 100 | P < 0.01 |
| Normal tissue | 2/6 | 33 | ||
| Prostate | Adenocarcinoma | 9/13 | 69 | 0.01 < P < 0.05 |
| Normal tissue | 1/6 | 17 | ||
| Colon | Adenocarcinoma | 17/17 | 100 | 0.01 < P < 0.05 |
| Normal tissue | 4/6 | 67 | ||
| Cerebrum | Astrocytoma | 17/17 | 100 | NS |
| Normal tissue | 7/7 | 100 | ||
| Uterus | Adenocarcinoma | 20/20 | 100 | NS |
| Normal tissue | 5/5 | 100 | ||
| Bladder | Transitional cell carcinoma | 18/20 | 90 | NS |
| Normal tissue | 1/1 | 100 | ||
| Ovary | Carcinoma | 20/30 | 67 | NS |
| Normal tissue | 4/6 | 67 | ||
| Breast | Carcinoma | 18/29 | 62 | NS |
| Normal tissue | 6/9 | 67 | ||
| Testis | Seminoma | 12/21 | 57 | NS |
| Normal tissue | 5/6 | 83 | ||
| Lung | Carcinoma | 14/25 | 56 | NS |
| Normal tissue | 1/1 | 100 | ||
| Stomach | Adenocarcinoma | 9/18 | 50 | NS |
| Normal tissue | 3/5 | 60 | ||
| Pancreas | Adenocarcinoma | 5/15 | 33 | NS |
| Normal tissue | 3/6 | 50 | ||
NS: not significant